UpToDate ✓

@UpToDate · joined 15 Apr 2011

Trusted clinical decision support for confident care. Evidence-based guidance—now with UpToDate® Expert AI, grounded in expert-authored content.

140 567Followers

241Following

10 925Posts total

7.8KViews on collected posts

Neueste Beiträge

UpToDate ✓@UpToDate15 Sep

UpToDate Expert AI now includes drug dosing guidance from UpToDate® Lexidrug™. Enterprise access to drug dosing can help: •Strengthen medication decision support •Advance medication safety and quality goals •Scale broader access to medication intelligence Read more: https://t

1.1K views · 0 likes · 0 reposts · 0 replies Open on X →

UpToDate ✓@UpToDate15 Sep

Every few months, early career doctors rotate into new wards, new systems, and fresh uncertainty. For NHS specialty registrar Dr. Emily Audet, trusted clinical decision support is the constant. UpToDate® Expert AI helps ease cognitive load and offers evidence-based reassurance h

1.5K views · 0 likes · 0 reposts · 0 replies Open on X →

UpToDate ✓@UpToDate14 Sep

Day 1 at the Becker’s IT + Revenue Cycle Conference is officially in the books, and what an incredible start! It was fantastic connecting with so many healthcare leaders, innovators, and industry peers throughout the day. Take a look at some highlights from today and stop by http

2.1K views · 0 likes · 0 reposts · 0 replies Open on X →

UpToDate ✓@UpToDate14 Sep

Pet owners expect the same care for their pets' meds as their own. Medi-Span Vet Meds helps retail pharmacists dispense vet prescriptions confidently, right in their existing workflow. Tap the $13B vet med market while keeping pets safe and building customer loyalty as a result.

1.4K views · 1 likes · 1 reposts · 0 replies Open on X →

UpToDate ✓@UpToDate14 Sep

🧠It's Clinical Challenge time! Today's question comes from our Anesthesiology specialty A 62-year-old man with type 2 diabetes takes a weekly glucagon-like peptide 1 receptor agonist (GLP1-RA). He is scheduled for elective surgery under general anesthesia. He has severe https://

0:05

1.7K views · 2 likes · 1 reposts · 0 replies Open on X →

Im Vergleich zu Konten gleicher Größe

5 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 100K–1M Follower. erreicht weniger Menschen als Konten gleicher Größe.

Medianaufrufe1 544dieses Konto5 995Median für 100K–1M

Reichweite, %1.10%dieses Konto1.62%Median für 100K–1M

Interaktion, %0.00%dieses Konto1.03%Median für 100K–1M

Kennzahl	Dieses Konto	Median für 100K–1M	Verhältnis
Medianaufrufe pro Beitrag	1 544	5 995	0.26×
Reichweite (Aufrufe ÷ Follower)	1.10%	1.62%	0.68×
Interaktionsrate	0.00%	1.03%	0.00×

Weitere Konten dieser Größe → Mit einem anderen Konto vergleichen → Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.7K14 Sep

1.4K

2.1K

1.5K15 Sep

1.1K

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.18%14 Sep

0.15%

0.00%

0.00%15 Sep

0.00%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 100K–1M accounts is 1.03%.

What the audience does

Likes42.9%3 in total

Reposts28.6%2 in total

Bookmarks28.6%2 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Neueste Beiträge

Im Vergleich zu Konten gleicher Größe

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Ähnliche Konten